Events
Egyptian Drug Authority Participates in Several Sessions at MedDevReg AfriSummit 2025 to Support Innovation and Develop the Continental Regulatory Framework
The Egyptian Drug Authority participated in several important sessions during the MedDevReg AfriSummit 2025, a continental summit focused on the regulation of medical devices, with the participation of African regulatory authorities and international organizations, aiming to support Africa’s collective efforts toward regulatory harmonization and to ensure the safety and quality of medical devices across the continent.
• Dr. Miriam Boulus, Head of the Central Administration of Medical Devices, participated in the opening session titled “The Role of the African Medical Device Forum in Shaping a Unified Regulatory Future for the Continent.”. She emphasized the EDA’s commitment to supporting African initiatives aimed at unifying regulatory policies and exchanging expertise, which strengthens continental integration in the field of medical devices.
• Dr. Doaa Mahrous, General Manager of the General Administration for Registration of Medical Devices, participated in the session “Regulatory Updates for Medical Devices in Africa,” where she presented the EDA’s efforts in developing a modern and efficient registration system that keeps pace with global developments and serves both the industrial and healthcare sectors in Egypt and Africa.
• In the session titled “Made in Africa – From Importation to Industrial Leadership,” Dr. Youstina Nabil, Senior Medical Device Registration Specialist, discussed the importance of enhancing local manufacturing, facilitating technology transfer, and supporting AMDF initiatives to harmonize standards and streamline the circulation of products within the continent.
• Dr. Sara Emad, Head of the Imported In-Vitro Diagnostics Registration Unit, reviewed the Authority’s efforts to develop the regulatory system for diagnostic reagents, ensuring their alignment with international quality and safety standards.
In the same context, Dr. Salah Allam, Manager of the Administration of the Inspection for Pharmacies and Warehouses, representing the Central Administration for Inspection of Pharmaceutical Establishments, participated in a main session titled “Securing the Future – A Collaborative Approach to Safeguarding the Medical Device Supply Chain in Africa.” He reviewed the regulatory procedures implemented by the EDA to ensure the quality and safe distribution of medical devices, confirming that Egypt’s regulatory system is fully aligned with international practices. He also highlighted that the EDA’s achievement of WHO Maturity Level 3 stands as a testament to its regulatory excellence and leadership in Africa.
These participations reaffirm the EDA’s leading role in promoting continental integration, regulatory harmonization, and local manufacturing of pharmaceutical products and medical devices — contributing to health security and sustainable development across Africa.
Tags
Egyptian Drug Authority
MedDevReg